CDMRP Tuberous Sclerosis Complex Research Program: Idea Development Award

The Idea Development Award promotes new ideas that are in the early stages of development and have the potential to yield high-impact findings and new avenues of investigation. Preliminary data should be presented. 

Focus Areas:

• Understanding and treating the features of TSC-Associated Neuropsychiatric Disorders (TAND) and reducing their impact, including pharmacological and behavioral interventions
• Strategies for eradicating tumors associated with TSC and TSC-associated lymphangioleiomyomatosis (LAM), including gaining a deeper mechanistic understanding of TSC signaling pathways and tumor microenvironment
• Preventing epilepsy, improving treatment, and mitigating neurodevelopmental outcomes associated with TSC-related seizures

It is expected that 3 awards will be granted.

Funding: $500,000 total.
Duration: 3 years

Research Authority due date: 23.6.22

Pre application (required) due date: 30.6.22

Full application due date: 28.7.22